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Cells that fail to divide during cytokinesis often arrest in
the next G1 phase by a mysterious mechanism that depends
upon p53. What triggers this arrest is unclear. New stud-
ies, including a report in this issue (Uetake and Sluder,
2004) suggest that this arrest does not occur because cells
are polyploid, are binucleate, have multiple centrosome,
or have failed cytokinesis, making this phenomenon even
more puzzling.
 
A hallmark of most cancer cells is that they are highly aneu-
ploid, whereas most somatic cells have stable ploidy. Poly-
ploidy has even been postulated to generate genetic instability
(Lengauer et al., 1998). It is unclear if normal somatic cells
maintain their ploidy simply by faithful mitotic segregation
of their chromosomes or if they have mechanisms to detect
aneuploidy and either correct this problem or block aneu-
ploid cells from further division cycles. A growing body of
work suggests that cells that fail to undergo cytokinesis activate
a “tetraploid checkpoint” that arrests them in the following
G1 in a p53-dependent manner. However, recent papers
suggest that polyploidy per se cannot trigger the p53 net-
work, and the in vivo relevance of this arrest is still unclear.
It is well established that p53 blocks cell cycle progression
in cells that fail cytokinesis, as many researchers have inde-
pendently generated polyploid cells that arrest in the follow-
ing G1 (Fig. 1). The original observation of this phenome-
non preceded the discovery of p53. Hirano and Kurimura
(1974) found SV40-infected cells did not arrest in G1 when
treated with cytochalasin, a drug that poisons actin and,
hence, prevents contraction of the cytokinetic furrow (Fig. 1
B). It is now known that SV40 infection inactivates p53.
Reid and colleagues (Cross et al., 1995) incubated mouse
embryo fibroblasts (MEFs) in nocodazole or colcemid, two
different microtubule-depolymerizing drugs, for 22 h, and
found that wild-type MEFs arrested with 4N ploidy, but
P53
 
 
 
/
 
 
 
 MEFs had rereplicated their chromosomes and be-
come 8N (Cross et al., 1995). Further studies demonstrated
that even though the cells were in nocodazole, the 4N cells
did not arrest in mitosis but escaped the spindle checkpoint
and arrested in the subsequent G1 phase in a state that had
many hallmarks of a p53 checkpoint arrest induced by DNA
damage (Fig. 1 C) (Lanni and Jacks, 1998; Minn et al.,
1996). It is worth pointing out that these experiments were
first seen in mouse cells that have a functional spindle check-
point but cannot maintain the mitotic arrest in nocodazole
for nearly as long as human cells. Margolis’s group generated
binucleate cells with dihydrocytochalasin B (Fig. 1 B)
(Andreassen et al., 2001), and once again p53-positive cells
arrested in the subsequent G1 phase whereas p53-minus
cells rereplicated their DNA to become 8N. While exploring
how overexpression of the oncogene Aurora A generated
multiple centrosomes, Erich Nigg’s group found that excess
Aurora A expression blocked cytokinesis (Fig. 1 B) (Meraldi
et al., 2002). They went on to show that these cells also
arrested in the following G1 in a p53-dependent manner.
Although it still has to be formally established, it is likely
that a common mechanism is activating p53 after each of
these treatments.
Since cancer cells often have extra chromosomes, it has
been postulated that there is an initial event causing cancer
cells to become polyploid and then reduced fidelity of chro-
mosome segregation results in subsequent aneuploidy that
drives the loss of heterozygosity of tumor suppressors. Thus,
the notion that p53 blocks the progression to S-phase in the
cells that are polyploid is satisfying, as it further explains the
almost universal loss of the p53 pathway during cancer
progression. However, deeper thinking suggests that “normal”
somatic cells are often polyploid, and the initial models may
be naïve. Polyploidy, both autopolyploidy and allopoly-
ploidy, is common among higher (angiosperm) plants but
relatively rare among animals and not restricted to any par-
ticular genus. Muller (1925) was the first to suggest that
polyploidy is rare in animals because of the evolution of sex
chromosomes and a chromosomal basis for sex determination.
Importantly, there are polyploid animals. A variety of frogs
and toads are tetraploid, most famous among them is 
 
Xenopus
laevis
 
. The brine shrimp (
 
Artemia franciscana)
 
 is tetraploid,
whereas the pine sawfly (
 
Diprion similie
 
) has diploid males
but tetraploid females. Increased ploidy has also been reported
in humans. Triploid and tetraploid fetuses often die and are
aborted in the first trimester, but there are many cases of
fetuses that survive to the third trimester and a small number
of cases of tetraploid live births (Edwards et al., 1994;
Nakamura et al., 2003). There are certain cell types in humans
that are polyploid; for example, megakaryocytes increase in
ploidy as part of their differentiation (Queisser et al., 1971).
 
Address correspondence to P. Todd Stukenberg, Department of Bio-
chemistry and Molecular Genetics, University of Virginia Medical
School, Charlottesville, VA 22908. Tel.: (434) 924-5252. Fax: (434)
924-5069. email: Pts7h@virginia.edu 
608 The Journal of Cell Biology 
 
|
 
 
 
Volume 165, Number 5, 2004
 
Although it is possible that polyploid organisms and cells
undergo adaptive events, these observations suggest that
polyploidy per se is not lethal at the cellular level.
A report in this issue provides new insight into the cause
of p53-dependent arrest. Uetake and Sluder found that tran-
sient treatment with very low concentrations of cytochalasin
D can block cytokinesis to generate binucleate cells but cells
treated this way did not arrest at G1 (Fig. 1 D) (Uetake and
Sluder, 2004). Using video microscopy, they followed binu-
cleate cells formed in these low cytochalasin D concentra-
tions and showed that they underwent mitosis and another
round of cytokinesis. The lack of the arrest was not caused
by the loss of the p53 pathway, since the same cells arrested
at the higher concentrations of cytochalasin D. Similarly,
Wong and Stearns fused human diploid foreskin fibroblasts
(which can also arrest as binucleates with high concentra-
tions of cytochalasin) and showed that the resulting binu-
cleate hybridomas entered S-phase without a prolonged ar-
rest (Wong, C., and T. Stearns, personal communication).
These simple experiments argue strongly that p53-depen-
dent arrest is not triggered by binucleation, polyploidy, mul-
tiple centrosomes, or failure of cytokinesis.
What is triggering the p53 network in tetraploid cells has
become the central enigma in this field. One clue comes
from the observation that there may be some cell type speci-
ficity. Margolis’s group originally used rat embryonic fibro-
blasts (Ref52 cells) (Andreassen et al., 2001) and Uetake and
Sluder found that these cells arrested even at the lower con-
centrations of cytochalasin D that did not block S-phase
progression in hTert-RPE1 cells or human primary foreskin
fibroblasts. Interestingly, the arrest in Ref52 cells could be
relieved by plating the cells on fibronectin rather than di-
rectly on glass (Uetake and Sluder, 2004). It is unclear why
fibronectin suppresses the arrest, but it is interesting that the
binding of integrins to fibronectin can regulate the actin and
microtubule cytoskeleton. Perhaps the disruption of the cy-
toskeleton during a failed cytokinesis generates a “dead end”
cytoskeletal complex that is activating p53 and the pathways
downstream of integrins can resolve these cytoskeleton net-
work problems.
To understand if this p53-dependent arrest actually pre-
vents cancer progression, not only does the signal need to be
determined but the conditions by which the arrest is nor-
mally triggered must be described. Most studies have used
drugs to trigger the arrest, with one exception from Brian
Reid’s group who found an increase in ploidy specifically in
p53
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 mice. 25 d after birth, the pancreases of 53
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 mice
have 
 
 
 
23% of 4N cells as compared with 7% in wild type.
Moreover, in transgenic mice that blocked p53 and other
proteins by expressing SV40 T-antigen under the elastase
promoter the number of polyploid cells in the pancreas was
 
 
 
45% (Cross et al., 1995). This report of p53 preventing
polyploidy in vivo suggests that this mysterious pathway may
still have an important role in preventing cancer progression.
 
The ideas in this review were the result of many conversations with
Daniel Burke.
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Figure 1. A summary of the experiments addressing the p53-
dependent G1 arrest after cytokinesis failure. See text for details.